- Home
- BCDA vs DDC Comparison
BCDA vs DDC Comparison
Compare BCDA & DDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- DDC
- Stock Information
- Founded
- BCDA N/A
- DDC 2012
- Country
- BCDA United States
- DDC Hong Kong
- Employees
- BCDA N/A
- DDC N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- DDC Metal Mining
- Sector
- BCDA Health Care
- DDC Basic Materials
- Exchange
- BCDA Nasdaq
- DDC Nasdaq
- Market Cap
- BCDA 7.9M
- DDC 6.9M
- IPO Year
- BCDA N/A
- DDC 2023
- Fundamental
- Price
- BCDA $2.05
- DDC $0.14
- Analyst Decision
- BCDA Strong Buy
- DDC Strong Buy
- Analyst Count
- BCDA 1
- DDC 2
- Target Price
- BCDA $25.00
- DDC $5.50
- AVG Volume (30 Days)
- BCDA 31.3K
- DDC 364.0K
- Earning Date
- BCDA 11-13-2024
- DDC 01-01-0001
- Dividend Yield
- BCDA N/A
- DDC N/A
- EPS Growth
- BCDA N/A
- DDC N/A
- EPS
- BCDA N/A
- DDC N/A
- Revenue
- BCDA $71,000.00
- DDC $28,978,254.00
- Revenue This Year
- BCDA N/A
- DDC N/A
- Revenue Next Year
- BCDA N/A
- DDC N/A
- P/E Ratio
- BCDA N/A
- DDC N/A
- Revenue Growth
- BCDA N/A
- DDC 14.42
- 52 Week Low
- BCDA $1.84
- DDC $0.14
- 52 Week High
- BCDA $10.80
- DDC $4.91
- Technical
- Relative Strength Index (RSI)
- BCDA 42.16
- DDC 31.03
- Support Level
- BCDA $2.00
- DDC $0.14
- Resistance Level
- BCDA $2.14
- DDC $0.17
- Average True Range (ATR)
- BCDA 0.16
- DDC 0.01
- MACD
- BCDA -0.00
- DDC 0.00
- Stochastic Oscillator
- BCDA 15.91
- DDC 7.69
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About DDC DDC Enterprise Limited
DDC Enterprise Ltd is a content driven consumer brand offering easy, convenient ready-to-heat , ready-to-cook and plant-based meal products i.e. meal products consisting largely or solely of vegetables, fruits, grains and other foods derived from plant-based protein, rather than animal protein) while promoting healthier lifestyle choices to Millennial and Generation Z customer-base. It is also engaged in the provision of advertising services and the operation of experience stores to offer cooking classes.